文献速递间质性肺疾病

6分钟步行距离预测非IPF纤维化间质性肺疾病的无肺移植生存

Use of 6-minute walk distance to predict lung transplant-free survival in fibrosing non-IPF interstitial lung diseases.
PubMed 文献 · Respirology · 2024-02-06

研究在发现队列(n=105)和验证队列(n=138)中评估基线及1年时FVC、DLCO和6MWD变化对无肺移植生存的预测价值。结果显示6MWD下降≥24m可显著且独立于FVC和DLCO下降预测无肺移植生存,敏感性和特异性高,且比ATS/ERS/JRS/ALAT功能标准更准确。

要点

  • 6MWD下降≥24m独立预测纤维化非IPF ILD患者的无肺移植生存。
  • 6MWD纵向变化与FVC、DLCO变化无强相关性,可互补评估疾病进展。
  • 6MWD下降预测准确性高于ATS/ERS/JRS/ALAT功能标准。

核心结论

  • 在纤维化非IPF间质性肺疾病中,6MWD纵向下降与较差生存相关,且独立于肺功能下降。

研究设计与样本

  • 发现队列(n=105)和验证队列(n=138)来自不同中心,评估基线及1年时FVC、DLCO和6MWD变化,主要终点为无肺移植生存。

主要发现

  • 两个队列平均随访均为3年,死亡和肺移植联合发生率分别为29%和21%。
  • 6MWD下降≥24m在两个队列中均显著且独立于FVC和DLCO下降预测无肺移植生存,敏感性和特异性高。
  • FVC和DLCO下降仍为无肺移植生存的显著预测因素,但6MWD下降比ATS/ERS/JRS/ALAT功能标准更准确。
  • 按基线FVC分层后结果仍得到证实。

关键数值与推荐

  • 6MWD下降≥24m为预测无肺移植生存的阈值,敏感性和特异性高。
  • 死亡和肺移植联合发生率在发现队列和验证队列分别为29%和21%。

临床怎么用

  • 6MWD纵向变化可整合入纤维化非IPF ILD患者的常规进展评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: The identification of progression in patients with fibrosing non-idiopathic pulmonary fibrosis (IPF) interstitial lung diseases (ILDs) represents an ongoing clinical challenge. Lung function decline alone may have significant limitations in the detection of clinically significant progression. We hypothesized that longitudinal changes of 6-min walk distance (6MWD) from baseline, simultaneously considered with measures of lung function, may independently predict survival and identifying clinically significant progression of disease. METHODS: Forced vital capacity (FVC), diffusing lung capacity (DLCO) and 6MWD were considered both at baseline and at 1 year in a discovery cohort (n = 105) and in a validation cohort (n = 138) from different centres. The primary endpoint was lung transplant (LTx)-free survival. RESULTS: Average follow-up was 3 years in both cohorts. Combined incidence of deaths and LTx was 29% and 21%, respectively. No collinearity and no strong correlations were observed among FVC, DLCO and 6MWD longitudinal changes. While age, gender and BMI were not significant, 6MWD decline ≥24 m predicted LTx-free-survival significantly and independently from FVC and DLCO declines, with high sensitivity and specificity, in both the discovery and the validation cohorts. Although FVC and DLCO declines remained significant predictors of LTx-free survival, 6MWD decline was more accurate than the proposed ATS/ERS/JRS/ALAT functional criteria. Results were confirmed after stratifying patients by baseline FVC. CONCLUSION: Longitudinal declines of 6MWD are associated with poor survival in fibrosing ILDs across a wide range of baseline severity, with high accuracy. 6MWD longitudinal decline is largely independent from lung function decline and may be integrated into the routine assessment of progression.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Zanini U, Luppi F, Kaur K, et al. Use of 6-minute walk distance to predict lung transplant-free survival in fibrosing non-IPF interstitial lung diseases. Respirology. 2024. PMID: 38320863. doi:10.1111/resp.14669

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。